Nintedanib: Patient-Friendly Guide (Australia)

Nintedanib is a targeted medicine used in certain lung conditions and some rare, specific cancers. This guide explains what nintedanib does, how it works, how it’s taken, key safety points, and practical tips for everyday use in Australia. Information here is general and not a substitute for personalised medical advice.

Quick Overview

• Medicine name: Nintedanib
• Medicinal class: Tyrosine kinase inhibitor (TKI)
• Common strengths: Varies by product; follow your local label and prescriber instructions.
• How it is taken: Usually by mouth, swallowed whole
• Typical schedule: Often twice daily for certain conditions
• Main benefit: Helps slow disease progression in selected conditions

Basic Product Information

Nintedanib is marketed under brand names depending on the country. In Australia, availability may vary by product presentation and approval status. Your pharmacist or prescriber can confirm the exact product and dose you have been given.

Nintedanib is intended for long-term use in appropriate conditions. Many people take it continuously, even when symptoms fluctuate, because its main effect is on disease behaviour rather than immediate symptom relief.

How Nintedanib Works (Mechanism of Action)

Nintedanib blocks specific signalling pathways involved in abnormal growth of blood vessels and fibrosis (scarring). By inhibiting multiple tyrosine kinases, it may reduce:

• Fibroblast activity involved in lung scarring
• Growth signals that contribute to tissue damage
• Tumour-related signalling in certain cancers where nintedanib is indicated

In simplified terms, nintedanib works like a “switch-off” for several growth and repair signals that can drive progressive disease.

Pharmacokinetics (How Your Body Handles Nintedanib)

Pharmacokinetics describes how the body absorbs, distributes, metabolises, and eliminates a medicine. Key points for nintedanib include:

Because nintedanib relies on liver metabolism, liver function tests are usually monitored during treatment.

Typical Use in Australia

Nintedanib is used for specific diagnoses where it has been shown to help slow disease progression. Its use is determined by clinical assessment and the medicine’s approved indications in Australia.

Common real-world contexts include:

• Progressive fibrosing interstitial lung diseases (ILD) in appropriate adults
• Idiopathic pulmonary fibrosis (IPF)
• Some forms of non-small cell lung cancer when used in combination with other therapies (where applicable)

If you are unsure which condition your treatment is for, check your medication label and your care plan.

Indications (Where Nintedanib May Be Used)

Indications can depend on the exact Australian product approval and whether it’s used alone or with other medicines. Typical approved uses include:

• Idiopathic pulmonary fibrosis (IPF)
• Systemic sclerosis–associated interstitial lung disease (SSc-ILD)
• Progressive fibrosing interstitial lung disease (PF-ILD)
• Non-small cell lung cancer (NSCLC) in selected patients, often in combination regimens (as approved for that product)

Your treating clinician can confirm which indication applies to you.

Dosing and Timing

Dosing must be individualised. The information below is general; always follow your medicine label and clinician’s instructions.

General dosing approach

• Common schedule: Many patients take nintedanib twice daily (morning and evening) for ILD-type indications.
• Swallow whole: Do not crush, split, or chew unless your specific product instructions say otherwise.
• Missed dose: If you miss a dose, take it when you remember unless it’s close to the next scheduled dose. Do not double up.
• Dose adjustments: Side effects such as diarrhoea, nausea, or elevated liver enzymes may require dose reduction or temporary interruption under medical supervision.

Timing with regular routines

Consistent timing helps maintain steady medicine exposure. Many people set two daily “anchors,” such as:

• Morning dose after breakfast
• Evening dose with dinner

If you have bowel side effects, you may find it easier to coordinate the dose with meals that suit you (see food interaction section).

Food Interactions and Alcohol

Food interactions

Food can influence how much nintedanib your body absorbs. For many patients, taking it with food is recommended and helps reduce gastrointestinal discomfort. However, the exact advice may depend on the product formulation and your clinician’s plan.

Practical approach:

• Take with food as advised (commonly with meals)
• Avoid large changes in meal timing day-to-day
• If you experience diarrhoea or nausea, ask your pharmacist whether changes to meal timing could help

Alcohol interactions

Alcohol may increase the risk of liver stress and can worsen gastrointestinal side effects. Because nintedanib is metabolised in the liver, discuss alcohol use with your clinician, especially if you have liver disease or abnormal liver tests.

General safety considerations:

• Limit alcohol if you have elevated liver enzymes or ongoing symptoms (fatigue, nausea, jaundice)
• Avoid binge drinking
• Report any signs of liver problems promptly

Medicine Interactions (Including Enzyme Effects)

Nintedanib interacts with other medicines because it is metabolised by liver enzymes (notably CYP3A4). Some medicines can increase nintedanib levels (raising side effects risk), while others can decrease levels (reducing effect).

Always tell your healthcare team about all medicines you use, including:

• Prescription medicines
• Over-the-counter products (e.g., cold/flu preparations)
• Herbal supplements (e.g., St John’s wort)
• Antacids or stomach acid medicines
• Any supplements or diet products

Examples of interaction types to consider

• Strong CYP3A4 inhibitors may raise nintedanib concentrations and increase toxicity risk.
• Strong CYP3A4 inducers may reduce nintedanib concentrations and lower effectiveness.
• Anticoagulants/antiplatelet agents may affect bleeding risk (particularly important in procedures or if you have bruising).
• Medicines affecting clotting require careful coordination.

Your pharmacist can check interactions for your full medication list.

Safety Profile: Common and Serious Side Effects

Like all medicines, nintedanib can cause side effects. Many are manageable, but some require urgent attention. If you experience concerning symptoms, seek medical advice promptly.

Common side effects

• Diarrhoea (often the most common)
• Nausea and/or vomiting
• Decreased appetite
• Abdominal pain or indigestion
• Fatigue
• Weight loss in some people
• Elevated liver enzymes on blood tests
• Headache and general aches (in some people)

Serious side effects (seek urgent medical help if severe)

• Severe or persistent diarrhoea, dehydration, dizziness, or inability to keep fluids down
• Signs of liver problems: yellowing of skin/eyes, dark urine, severe right upper abdominal pain, marked fatigue
• Bleeding: unusual bruising, nosebleeds that won’t stop, blood in stool or vomit, coughing blood
• Blood clot or stroke symptoms (sudden weakness, trouble speaking, chest pain, shortness of breath)
• Severe skin reactions (blistering rash, peeling skin)
• Eye problems such as severe pain, vision changes

This is not a complete list. For full details, refer to the product information supplied by your pharmacy.

Practical Use Tips (Make Treatment Easier)

1) Manage diarrhoea early

Diarrhoea can begin soon after starting or after dose changes. Early management often helps you stay on track. Consider the following practical steps:

• Stay hydrated (water, oral rehydration solutions)
• Use simple foods if tolerated (e.g., rice, toast, bananas)
• Report ongoing diarrhoea to your clinician; you may need anti-diarrhoeal treatment or dose adjustment
• Avoid triggering foods (very fatty, very spicy, alcohol)

2) Protect your liver

• Attend scheduled blood tests
• Avoid heavy alcohol intake
• Let your clinician know about symptoms that could indicate liver stress

3) Track symptoms and side effects

A short daily note can help your care team respond quickly. For example:

• Number of diarrhoea episodes
• Nausea level and triggers
• Any bleeding/bruising
• Weight changes

4) Take consistent doses

• Set reminders on your phone
• Keep a supply where you will remember it (e.g., near your meal routine)
• If you travel, plan for temperature storage and carry original packaging

5) Tell your team about procedures

If you are planning surgery or dental procedures, inform your clinician because bleeding and healing considerations may apply.

When to Seek Medical Advice

Contact your healthcare team urgently if you have:

• Severe diarrhoea or dehydration (faintness, inability to drink)
• Vomiting that prevents taking your medicine
• Yellowing of skin/eyes, severe abdominal pain, or dark urine
• Uncontrolled bleeding or coughing up blood
• Chest pain, sudden breathlessness, or signs of stroke

For non-urgent concerns, speak with your pharmacist for advice on supportive measures and interaction checks.

Alternative Options

“Alternative” depends on your diagnosis, stage, and previous treatments. In ILD conditions, clinicians may consider other antifibrotic therapies or supportive regimens; in cancers, options may include different systemic treatments.

Examples of alternatives that may be discussed (not exhaustive):

• Other antifibrotic medicines for certain idiopathic or progressive fibrosing ILDs
• Immunomodulatory or anti-inflammatory therapies for specific ILD subtypes (as appropriate)
• Different cancer regimens depending on tumour type and prior treatments
• Supportive care such as pulmonary rehabilitation, oxygen therapy, and symptom management

Your clinician can explain why nintedanib is recommended for your specific situation and what other pathways are available.

Recent Guidance and Monitoring (General Overview)

Treatment recommendations for fibrosing lung diseases and lung cancer can evolve as new evidence becomes available. In practice, clinicians typically focus on:

• Regular monitoring for side effects (especially diarrhoea and liver enzymes)
• Assessment of treatment benefit over time using clinical and, when relevant, imaging or lung function measures
• Dose adjustment strategies if adverse effects occur
• Medication review to reduce interaction risks

Your care plan should include how and when your blood tests and follow-up visits will occur.

Market and Legal Context in Australia

In Australia, medicines are supplied through a regulated healthcare system. Access can be influenced by:

• Australian regulatory status and Therapeutic Goods Administration (TGA) listings/approvals
• Whether the product is included on relevant national or state medicine schemes
• Prescriber assessment of indication and suitability
• Pharmacist dispensing requirements and documentation rules

Availability can vary between states and depending on supply chain factors. An online pharmacy typically provides ordering and delivery services subject to verification and Australian requirements.

Delivery and Availability

Availability and delivery times can differ. When ordering nintedanib online, you may notice:

• Medication strength and quantity: Ensure the product matches your label
• Stock variation: Some strengths may have limited local stock at times
• Delivery service: Your order may be shipped via standard or express post depending on location
• Packaging: Medicines are dispatched in accordance with safety and transport requirements

If you need a refill, allow extra time for processing and shipping—especially if you travel or have upcoming appointments. Your pharmacist can advise on lead times.

FAQ (Frequently Asked Questions)

1) What is nintedanib used for?

Nintedanib is used for certain fibrosing lung conditions (including idiopathic pulmonary fibrosis and other progressive fibrosing interstitial lung diseases) and for selected cancers where it is indicated. Your diagnosis determines whether it is appropriate.

2) How should I take nintedanib?

Follow your product label and clinician’s instructions. In many cases it is taken twice daily and swallowed whole. Taking it with food is commonly recommended. Do not crush or chew tablets unless your product guidance specifically allows it.

3) What should I do if I miss a dose?

If you miss a dose, take it when you remember unless it is close to your next scheduled dose. Do not take double doses to “catch up.” If you’re unsure, ask your pharmacist for advice.

4) Can I take nintedanib with food?

Food can affect absorption and may help reduce gastrointestinal side effects. Many patients are advised to take nintedanib with meals. Check the instructions for your specific product and discuss any dietary concerns with your pharmacist.

5) What if I get diarrhoea?

Diarrhoea is a common side effect. Start by focusing on hydration and simple foods. Contact your clinician promptly if it is severe, persistent, or causing dehydration. Dose adjustment or anti-diarrhoeal treatment may be needed.

6) Does nintedanib affect the liver?

Yes, nintedanib can increase liver enzymes in some people. Regular blood tests are typically part of monitoring. Seek medical advice if you develop symptoms such as yellowing of the skin/eyes or dark urine.

7) Are there medicine interactions I should know about?

Yes. Because nintedanib is metabolised by liver enzymes (including CYP3A4), interacting medicines can change nintedanib levels. Tell your pharmacist about all medicines and supplements you take, including herbal products.

8) Can I drink alcohol while taking nintedanib?

Alcohol may increase liver stress and can worsen gastrointestinal side effects. Discuss your alcohol intake with your clinician, especially if you have liver issues or abnormal liver tests.

9) What monitoring will I need?

Monitoring commonly includes blood tests for liver enzymes and follow-up reviews for side effects like diarrhoea and bleeding. Your clinician will tailor the plan to your condition and response.

10) What are the warning signs that need urgent help?

Seek urgent medical advice for severe diarrhoea with dehydration, signs of liver problems (e.g., yellow skin/eyes), serious bleeding, severe allergic-type reactions, chest pain, sudden breathlessness, or stroke-like symptoms.

Important Note

This content is for general education. Individual dosing, monitoring, and safety advice depend on your diagnosis, medical history, liver function, other medicines, and how you respond to treatment. Always use the information on your medicine label and talk to your pharmacist or clinician if you have questions.